CCNB1 and esophageal squamous cell carcinoma: It has been reported that overexpression of CCNB1 was correlated with adverse pathological types and clinical outcomes [32, 33], such as BC [34–36], colon adenocarcinoma [31], non-small cell lung cancer [37] and esophageal squamous cell cancer [38].